A BIO-MEDICAL company which has pioneered a technology to speed up the diagnosis of cervical cancer will be moving to the North West after raising nearly £1m to fund investment.Zilico, which was originally spun out from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, will be headquartered in Manchester after securing £750,000 from the The North West Fund for Biomedical and raising a further £235,000 from new and existing investors, including Fusion IP.Zilico is developing a syste......for the full story register now for free or login below...